Following Elanco Animal Health?
Get the free weekly contract digest
The latest new contracts, like Elanco Animal Health’s — who’s behind them and what they mean, delivered to your inbox every week. No credit card, unsubscribe anytime.
Weekly Digest
New new contracts, summarized for you
Straight to Inbox
No login, no app to check — it comes to you
Contract Trends
See who's moving and how much in your market
No credit card required Weekly contract digest
Contract Type
contract
Description
Elanco Animal Health Incorporated provided an update on its relationship with contract manufacturing supplier, TriRx Speke Ltd, indicating a reduction of approximately $5 million to $10 million of adjusted EBITDA in 2024 related to the situation. Despite this, Elanco continues to expect to deliver its full-year adjusted EBITDA guidance of $900 million to $940 million.
Agreement Insights
Based on industry dataContract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months